These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1199 related items for PubMed ID: 16515026

  • 41. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD.
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [Abstract] [Full Text] [Related]

  • 42. Ulcerative colitis in Stockholm County--a study of epidemiology, prognosis, mortality and cancer risk with special reference to a surveillance program.
    Broström O.
    Acta Chir Scand Suppl; 1986 Jul; 534():1-60. PubMed ID: 3472421
    [Abstract] [Full Text] [Related]

  • 43. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.
    Anticancer Res; 2004 Jul; 24(5B):3121-7. PubMed ID: 15510599
    [Abstract] [Full Text] [Related]

  • 44. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.
    Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A.
    Gastroenterology; 2006 Apr; 130(4):1030-8. PubMed ID: 16618396
    [Abstract] [Full Text] [Related]

  • 45. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Bryant SC, Sandborn WJ, Smyrk TC.
    Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
    [Abstract] [Full Text] [Related]

  • 46. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR.
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM, Berg AS, Harris LR, Brinton DL, Hegarty JP, Deiling SM, Stewart DB, Koltun WA.
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [Abstract] [Full Text] [Related]

  • 49. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
    Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Scand J Gastroenterol; 2009 Aug; 44(4):431-40. PubMed ID: 19101844
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
    Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E, ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU).
    J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
    [Abstract] [Full Text] [Related]

  • 53. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, Prytz H, Hultcrantz R, Lööf LA, Sandberg-Gertzén H, Almer S, Askling J, Ehlin A, Ekbom A.
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [Abstract] [Full Text] [Related]

  • 54. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
    Pongprasobchai S, Manatsathit S, Leelakusolvong S, Sattawatthamrong Y, Boonyapisit S.
    J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
    [Abstract] [Full Text] [Related]

  • 55. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J.
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [Abstract] [Full Text] [Related]

  • 56. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998 Oct; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Change in location of colorectal cancer in Hungarian patients between 1993-2004].
    Fuszek P, Horváth HC, Speer G, Papp J, Haller P, Halász J, Járay B, Székely E, Schaff Z, Papp A, Bursics A, Harsányi L, Lukovich P, Kupcsulik P, Hitre E, Lakatos PL.
    Orv Hetil; 2006 Apr 23; 147(16):741-6. PubMed ID: 16711260
    [Abstract] [Full Text] [Related]

  • 59. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.
    Lashner BA, Provencher KS, Bozdech JM, Brzezinski A.
    Am J Gastroenterol; 1995 Mar 23; 90(3):377-80. PubMed ID: 7872273
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.